Table I.
Association between miR-202 expression and clinicopathological parameters in 56 patients with hepatocellular carcinoma.
| miR-202 expression | ||||
|---|---|---|---|---|
| Clinicopathological parameters | Total | High (n=27) | Low (n=29) | P-value |
| Age, years | 0.643 | |||
| ≤55 | 41 | 19 | 22 | |
| >55 | 15 | 8 | 7 | |
| Sex | 0.422 | |||
| Male | 43 | 22 | 21 | |
| Female | 13 | 5 | 8 | |
| Tumor size, cm | 0.015 | |||
| <5 | 30 | 19 | 11 | |
| ≥5 | 26 | 8 | 18 | |
| Differentiation | 0.672 | |||
| Well and moderately | 40 | 20 | 20 | |
| Poor | 16 | 7 | 9 | |
| AFP (ng/ml) | 0.336 | |||
| <400 | 18 | 7 | 11 | |
| ≥400 | 38 | 20 | 18 | |
| Vascular invasion | 0.012 | |||
| Negative | 34 | 21 | 13 | |
| Positive | 22 | 6 | 16 | |
| TNM stage | 0.035 | |||
| I–II | 38 | 22 | 16 | |
| III–IV | 18 | 5 | 13 | |
miR, microRNA; AFP, α-fetoprotein; TNM, Tumor, Node and Metastasis.